ZetrOZ Systems

ZetrOZ Systems is a private medical device company founded in 2010, pioneering the field of sustained acoustic medicine (sam®) with its wearable, long-duration, low-intensity ultrasound devices. The company's core technology, OZ Inside™, is protected by over 46 patents and has been developed with significant federal funding from agencies like the NIH, NSF, DOD, and NASA. ZetrOZ is in the commercial stage, with its flagship sam® product line FDA-cleared for treating musculoskeletal pain and injuries, and it maintains a strong focus on US-based manufacturing and strategic partnerships in sports medicine.

OZ Inside™: A patented ultra-low impedance ultrasound miniaturization technology enabling wearable, long-duration, low-intensity Sustained Acoustic Medicine (sam®). It is a flexible platform for non-invasive, drug-free treatment to accelerate tissue healing and relieve pain.

ZetrOZ competes in the broad pain management and physical therapy markets against traditional therapeutic ultrasound machines, TENS units, and pharmaceutical options. Its primary differentiation is the wearable, long-duration application of ultrasound (sam®), a niche it currently leads with a strong patent portfolio, though larger players could eventually enter the space.